Ophthalmology

Medical Oncology

Questions discussed in this category

What supportive care measures do you prioritize to manage or prevent toxicity in patients receiving Dato-DXd?

How do you manage the severe adverse drug reaction of central serous retinopathy with MEK inhibitors?

If a patient develops central serous retinopathy on a MEK inhibitor despite dose reductions, is it ok to switch to a different BRAF/MEK combination?

2 Answers available

How do you manage a twice-recurrent mucinous adenocarcinoma of the lower eyelid with direct involvement of the lateral rectus muscle and lacrimal duct?

Latest PET-CT shows no evidence of distant metastasis

2 Answers available

How do you manage Cancer-Associated Retinopathy (CAR) in a patient who doesn’t have a known cancer diagnosis, given the difficulty in finding the underlying cancer and the risks of using immunosuppressive treatments to preserve vision?

1 Answer available

How would you approach a patient who is unable to undergo the recommended ophthalmologic examinations during treatment with mirvetuximab soravtansine?

For some patients, it may be overburdensome to make an extra trip to an ophthalmologist every other cycle. They may live far away from an ophthalmolog...

1 Answer available

How do you manage dry eye related to Pluvicto Lu-177?

2 Answers available

How do you integrate ophthalmic exam and surveillance into routine visits for cervical cancer patients receiving tisotumab vedotin?

2 Answers available

How do you manage MEK inhibitor induced ocular adverse events?

1 Answer available

How would you approach a symptomatic patient with with a history of whole brain RT with new bilateral MRI enhancing lesions within the optic nerves?

Would you suspect progressive disease v. radiation necrosis vs optic neuritis due to immunotherapy. Eyes were within radiation field 8 months ago.&nbs...

1 Answer available

Papers discussed in this category

JAMA ophthalmology, 2016-08-01

Subretinal Fluid Associated With MEK Inhibitor Use in the Treatment of Systemic Cancer.

N Engl J Med, 2021 Jun 23

Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024 Sep 12

Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01.

Ophthalmology

Medical Oncology

Questions discussed in this category

Papers discussed in this category

Related Topics in Ophthalmology